Stone RM - Search Results

1

Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial.

Larson RA, Mandrekar SJ, Huebner LJ, Sanford BL, Laumann K, Geyer S, Bloomfield CD, Thiede C, Prior TW, Döhner K, Marcucci G, Voso MT, Klisovic RB, Galinsky I, Wei AH, Sierra J, Sanz MA, Brandwein JM, de Witte T, Niederwieser D, Appelbaum FR, Medeiros BC, Tallman MS, Krauter J, Schlenk RF, Ganser A, Serve H, Ehninger G, Amadori S, Gathmann I, Döhner H, Stone RM. Larson RA, et al. Among authors: stone rm. Leukemia. 2021 Sep;35(9):2539-2551. doi: 10.1038/s41375-021-01179-4. Epub 2021 Mar 2. Leukemia. 2021. PMID: 33654204 Free PMC article. Clinical Trial.

2

A phase I study of intermittent continuous infusion high dose cytosine arabinoside for acute leukemia.

Stone RM, Spriggs DR, Dhawan RK, Arthur KA, Mayer RJ, Kufe DW. Stone RM, et al. Leukemia. 1990 Dec;4(12):843-7. Leukemia. 1990. PMID: 2243507

3

Detection of tumor necrosis factor gene expression at a cellular level in human acute myeloid leukemias.

Wakamiya N, Stone R, Takeyama H, Spriggs D, Kufe D. Wakamiya N, et al. Leukemia. 1989 Jan;3(1):51-6. Leukemia. 1989. PMID: 2642577

4

The approach to the elderly patient with acute myeloid leukemia.

Stone RM, Mayer RJ. Stone RM, et al. Hematol Oncol Clin North Am. 1993 Feb;7(1):65-79. Hematol Oncol Clin North Am. 1993. PMID: 7680642 Review.

5

A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.

Larson RA, Dodge RK, Burns CP, Lee EJ, Stone RM, Schulman P, Duggan D, Davey FR, Sobol RE, Frankel SR, et al. Larson RA, et al. Among authors: stone rm. Blood. 1995 Apr 15;85(8):2025-37. Blood. 1995. PMID: 7718875 Free article. Clinical Trial.

6

All-trans retinoic acid induces monocyte growth factor receptor (c-fms) gene expression in HL-60 leukemia cells.

Hsu HC, Yang K, Kharbanda S, Clinton S, Datta R, Stone RM. Hsu HC, et al. Among authors: stone rm. Leukemia. 1993 Mar;7(3):458-62. Leukemia. 1993. PMID: 8445950

7

Treatment of the newly diagnosed adult with de novo acute myeloid leukemia.

Stone RM, Mayer RJ. Stone RM, et al. Hematol Oncol Clin North Am. 1993 Feb;7(1):47-64. Hematol Oncol Clin North Am. 1993. PMID: 8449864 Review.

8

Acute myeloid leukemia-type chemotherapy for newly diagnosed patients without antecedent cytopenias having myelodysplastic syndrome as defined by French-American-British criteria: a Cancer and Leukemia Group B Study.

Bernstein SH, Brunetto VL, Davey FR, Wurster-Hill D, Mayer RJ, Stone RM, Schiffer CA, Bloomfield CD. Bernstein SH, et al. Among authors: stone rm. J Clin Oncol. 1996 Sep;14(9):2486-94. doi: 10.1200/JCO.1996.14.9.2486. J Clin Oncol. 1996. PMID: 8823327

9

Bryostatin 1: differentiating agent from the depths.

Stone RM. Stone RM. Leuk Res. 1997 May;21(5):399-401. doi: 10.1016/s0145-2126(96)00123-3. Leuk Res. 1997. PMID: 9225066 Review. No abstract available.

10

A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111.

Larson RA, Dodge RK, Linker CA, Stone RM, Powell BL, Lee EJ, Schulman P, Davey FR, Frankel SR, Bloomfield CD, George SL, Schiffer CA. Larson RA, et al. Among authors: stone rm. Blood. 1998 Sep 1;92(5):1556-64. Blood. 1998. PMID: 9716583 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

530 results

Search Page